Episode Details

Back to Episodes
Earlier treatment with biologics to reduce the risk of organ damage in systemic lupus erythematosus (SLE) Sponsored by GSK US Medical Affairs

Earlier treatment with biologics to reduce the risk of organ damage in systemic lupus erythematosus (SLE) Sponsored by GSK US Medical Affairs

Episode 1248 Published 1 year, 9 months ago
Description

Learn about the importance of reducing organ damage and corticosteroid-associated toxicity in SLE, and how biologics may help to change the course of the disease by targeting its underlying mechanisms.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us